Drug selection in a patient with a history of hypersensitivity reactions: A practical approach for the orthopedist

Orthopedics

Volumn 30, Issue 11, 2007, Pages 920-924

  Thompson, Lisa A ^a,c   Lewis, Daniel A ^a   Davis, George A ^a   Smith, Kelly M ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ALENDRONIC ACID; ANTIHISTAMINIC AGENT; BETA LACTAM ANTIBIOTIC; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CEPHALOSPORIN; CHONDROITIN; CLINDAMYCIN; CODEINE; CORTICOSTEROID; DICLOFENAC; GLUCOSAMINE; LOCAL ANESTHETIC AGENT; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PARATHYROID HORMONE[1-34]; PENICILLIN G; PETHIDINE; RALOXIFENE; RANITIDINE; SULFONAMIDE; TRAMADOL; UNINDEXED DRUG; AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS; ANTIINFECTIVE AGENT; BONE DENSITY CONSERVATION AGENT;

ALLERGIC RASH; ALLERGY TEST; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBIOTIC THERAPY; ASTHMA; CLINICAL FEATURE; CONTACT DERMATITIS; CROSS REACTION; DESENSITIZATION; DRUG CONTRAINDICATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INFORMATION; DRUG PACKAGING; DRUG PREFERENCE; DRUG SENSITIVITY; DRUG STRUCTURE; DRUG USE; EDEMA; ERYTHEMA; FEVER; HEPATITIS; HUMAN; INJECTION SITE PRURITUS; INJECTION SITE REACTION; LOW DRUG DOSE; MACULOPAPULAR RASH; MEDICAL SPECIALIST; NOSE IRRITATION; ORTHOPEDICS; OSTEOARTHRITIS; OSTEOPOROSIS; OSTEOSARCOMA; PAIN; PATIENT INFORMATION; PATIENT SELECTION; PENICILLIN ALLERGY; PRESCRIPTION; PRURITUS; REVIEW; RHINITIS; SKIN EXFOLIATION; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; URTICARIA; IMMUNOLOGY; INFECTION;

ANTI-BACTERIAL AGENTS; BONE DENSITY CONSERVATION AGENTS; CHONDROITIN; DRUG HYPERSENSITIVITY; GLUCOSAMINE; HUMANS; INFECTION; ORTHOPEDICS; OSTEOARTHRITIS; OSTEOPOROSIS; PAIN; SENSORY SYSTEM AGENTS;

EID: 38349176855     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20071101-08     Document Type: Review

References (27)

1. MacPherson R, Willcox C, Chow C, Wang A. Anaesthetist's responses to patients' self-reported drug allergies. Br J Anaesth. 2006; 97:634-639.
2. Sylvia LM. Drug allergy and pseudoallergy. In: Tisdale JE, Miller DA, eds. Drug-Induced Diseases: Prevention, Detection, and Management. Bethesda, MD: American Society of Health-System Pharmacists; 2005:27-55.
3. Tilles SA, Slatore CG. Hypersensitivity reactions to non-beta-lactam antibiotics. Clin Rev Allergy Immunol. 2003; 24:221-228'
4. Taylor LM, Smith KM. The paradox of heparin-induced thrombocytopenia: the initial management. Orthopedics. 2005; 28:559-562.
5. Gadde J, Spence M, Wheeler B, Adkinson N Jr. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA. 1993; 270:2456-2463.
6. Robinson JL, Hameed T, Carr S. Practical aspects of choosing an antibiotic for patients with a reported allergy to an antibiotic. Clin Infect Dis. 2002; 35:26-31.
7. Solensky R. Hypersensitivity reactions to beta-lactam antibiotics. Clin Rev Allergy Immunol. 2003; 24:201-220.
8. Pichichero ME, Casey JR. Safe use of selected cephalosporins in penicillin-allergic patients: A meta-analysis. Otolaryngol Head Neck Surg. 2007; 136:340-347.
9. Mazur N, Greenberger PA, Regalado J. Clindamycin hypersensitivity appears to be rare. Ann Allergy Asthma Immunol. 1999; 82:443-445.
10. Chiou CS, Lin SM, Lin SP, Chang WG, Chan KH, Ting CK. Clindamycin-induced anaphylactic shock during general anesthesia. J Chin Med Assoc. 2006; 69:549-551.
11. Gutstein HB, Akil H. Opioid analgesics. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2006:547-590.
12. Golembiewski JA. Allergic reactions to drugs: implications for perioperative care. J Perianesthes Nurs. 2002; 17:393-398.
13. Grand S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004; 43:879-923.
14. Ultram ER. [package insert]. Raritan, NJ: Pricara; 2006.
15. van Puijenbroek E, Egberts AC, Meyboom RH, Leufkens HG. Different risks for NSAID-induced anaphylaxis. Ann Pharmacother. 2002; 36:24-29.
16. Hansen KE, Elliott ME. Osteoarthritis. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. 6th ed. New York, NY: McGraw-Hill; 2005:1685-1703.
17. Namazy J, Simon R. Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol. 2002; 89:542-550.
18. Kong JS, Teuber SS, Gershwin ME. Aspirin and nonsteroidal anti-inflammatory drug hypersensitivity. Clin Rev Allergy Immunol. 2007; 32:97-110.
19. Boren E, Teuber SS, Naguwa SM, Gershwin ME. A critical review of local anesthetic sensitivity. Clin Rev Allergy Immunol. 2007;32:119-128.
20. Siminoski K, Josse RG. Calcitonin in the treatment of osteoporosis. Can Med Assoc J. 1996; 155:962-965.
21. Porcel S, Cumplido J, de la Hoz B, Cuevas M, Losada E. Anaphylaxis to calcitonin. Allergol Immunopathol (Madr). 2000; 28:243-245.
22. Piccone U, Pala M, Caprari M. Calcitonin-induced anaphylactic shock. Case report and review of the literature. Minerva Cardioangiol. 1994; 42:435-441.
23. Biswas PN, Wilton LV, Shakir SA. Pharmacovigilance study of alendronate in England. Osteoporos Int. 2003; 14:507-514.
24. McCarus DC. Fracture prevention in postmenopausal osteoporosis: A review of treatment options. Obstetrical and Gynecological Survey. 2005; 61:39-50.
25. Forteo. [package insert]. Indianapolis, IN: Eli Lilly and Company; 2002.
26. Villacis J, Rice T, Bucci L, et al. Do shrimp-allergic individuals tolerate shrimp-derived glucosamine? Clin Exp Allergy. 2006; 36:1457-1461.
27. Gruchalla RS. Drug allergies. Primary Care: Clinics in Office Practice. 1998; 25:791-807.